0001213900-23-096503.txt : 20231218
0001213900-23-096503.hdr.sgml : 20231218
20231218161524
ACCESSION NUMBER: 0001213900-23-096503
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231215
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feldmann Marc
CENTRAL INDEX KEY: 0001832327
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 231493902
MAIL ADDRESS:
STREET 1: 5 DURHAM TERRACE
CITY: LONDON
STATE: X0
ZIP: W25PB
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
X0508
4
2023-12-15
0
0001690080
180 Life Sciences Corp.
ATNF
0001832327
Feldmann Marc
3000 EL CAMINO REAL, BLDG. 4,
SUITE 200
PALO ALTO
CA
94306
1
0
0
0
0
Common Stock
2023-12-15
4
S
0
25000
0.188
D
115497
D
Effective on December 15, 2023, Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, sold 25,000 shares of common stock of the Issuer to Dr. James N. Woody, the Chief Executive Officer of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.
/s/ Sir Marc Feldmann, Ph.D.
2023-12-18